新型非肽血管紧张素AT1受体拮抗剂LR-B/081的分子药理学研究

Anna R. Renzetti , Marco Criscuoli , Aldo Salimbeni , Alessandro Subissi
{"title":"新型非肽血管紧张素AT1受体拮抗剂LR-B/081的分子药理学研究","authors":"Anna R. Renzetti ,&nbsp;Marco Criscuoli ,&nbsp;Aldo Salimbeni ,&nbsp;Alessandro Subissi","doi":"10.1016/0922-4106(95)90028-4","DOIUrl":null,"url":null,"abstract":"<div><p>This report describes the molecular pharmacological properties of LR-B/081 (methyl 2-[[4-butyl-2-methyl-6-oxo-5-[ [2′-(1H-tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-1 (6H)-pyrimidinyl]methyl]-3-thiophenecarboxilate), a novel non-peptide angiotensin II receptor antagonist. This compound potently displaced [<sup>3</sup>H]angiotensin II from angiotensin AT<sub>1</sub> (<em>K</em><sub>i</sub> = 1.4 nM, rat adrenal cortex), but not from angiotensin AT<sub>2</sub> (<em>K</em><sub>i</sub> &gt; 1 <em>ω</em>M, bovine cerebellar cortex) receptors and did not show affinity for other receptor systems (<em>K</em><sub>i</sub> &gt; 10 <em>ω</em>M). In saturation studies, LR-B/081 both increased <em>K</em><sub><em>D</em></sub> and decreased <em>B</em><sub><em>max</em></sub> values in a dose-dependent fashion. The rate of dissociation of [<sup>3</sup>H]angiotenin II from angiotensin AT<sub>1</sub> receptors was not affected by the presence of 1 ωM LR-B/081 and the association rate of [<sup>3</sup>H]angiotensin II was not decreased by the presence of 1 or 30 nM LR-B/081, indicating that the <em>B</em><sub>max</sub> reduction was not due to an allosteric interaction or to a delay in reaching the steady-state conditions. These data underline the complexity of the antagonistic nature of LR-B/081, presenting features of both competitive and noncompetitive antagonism.</p></div>","PeriodicalId":100502,"journal":{"name":"European Journal of Pharmacology: Molecular Pharmacology","volume":"290 2","pages":"Pages 151-156"},"PeriodicalIF":0.0000,"publicationDate":"1995-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0922-4106(95)90028-4","citationCount":"6","resultStr":"{\"title\":\"Molecular pharmacology of LR-B/081, a new non-peptide angiotensin AT1 receptor antagonist\",\"authors\":\"Anna R. Renzetti ,&nbsp;Marco Criscuoli ,&nbsp;Aldo Salimbeni ,&nbsp;Alessandro Subissi\",\"doi\":\"10.1016/0922-4106(95)90028-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>This report describes the molecular pharmacological properties of LR-B/081 (methyl 2-[[4-butyl-2-methyl-6-oxo-5-[ [2′-(1H-tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-1 (6H)-pyrimidinyl]methyl]-3-thiophenecarboxilate), a novel non-peptide angiotensin II receptor antagonist. This compound potently displaced [<sup>3</sup>H]angiotensin II from angiotensin AT<sub>1</sub> (<em>K</em><sub>i</sub> = 1.4 nM, rat adrenal cortex), but not from angiotensin AT<sub>2</sub> (<em>K</em><sub>i</sub> &gt; 1 <em>ω</em>M, bovine cerebellar cortex) receptors and did not show affinity for other receptor systems (<em>K</em><sub>i</sub> &gt; 10 <em>ω</em>M). In saturation studies, LR-B/081 both increased <em>K</em><sub><em>D</em></sub> and decreased <em>B</em><sub><em>max</em></sub> values in a dose-dependent fashion. The rate of dissociation of [<sup>3</sup>H]angiotenin II from angiotensin AT<sub>1</sub> receptors was not affected by the presence of 1 ωM LR-B/081 and the association rate of [<sup>3</sup>H]angiotensin II was not decreased by the presence of 1 or 30 nM LR-B/081, indicating that the <em>B</em><sub>max</sub> reduction was not due to an allosteric interaction or to a delay in reaching the steady-state conditions. These data underline the complexity of the antagonistic nature of LR-B/081, presenting features of both competitive and noncompetitive antagonism.</p></div>\",\"PeriodicalId\":100502,\"journal\":{\"name\":\"European Journal of Pharmacology: Molecular Pharmacology\",\"volume\":\"290 2\",\"pages\":\"Pages 151-156\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0922-4106(95)90028-4\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmacology: Molecular Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0922410695900284\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmacology: Molecular Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0922410695900284","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

摘要

本文报道了新型非肽血管紧张素II受体拮抗剂LR-B/081(甲基2-[[4-丁基-2-甲基-6-氧-5-[[2 ' -(1h -四唑-5-基)[1,1 ' -联苯]-4-基]甲基]-1 (6H)-嘧啶基]甲基]-3-噻吩甲酸酯)的分子药理学性质。该化合物能有效取代血管紧张素AT1中的[3H]血管紧张素II (Ki = 1.4 nM,大鼠肾上腺皮质),但不能取代血管紧张素AT2 (Ki >1 ωM,牛小脑皮质)受体,对其他受体系统没有亲和力(Ki >10 Mω)。在饱和研究中,LR-B/081以剂量依赖的方式增加KD和降低Bmax值。1 ωM LR-B/081的存在不影响[3H]血管紧张素II与血管紧张素AT1受体的解离速率,1 nM或30 nM LR-B/081的存在不降低[3H]血管紧张素II的结合速率,表明Bmax的降低不是由于变弹性相互作用或延迟达到稳态条件。这些数据强调了LR-B/081拮抗性质的复杂性,呈现出竞争性和非竞争性拮抗的特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Molecular pharmacology of LR-B/081, a new non-peptide angiotensin AT1 receptor antagonist

This report describes the molecular pharmacological properties of LR-B/081 (methyl 2-[[4-butyl-2-methyl-6-oxo-5-[ [2′-(1H-tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-1 (6H)-pyrimidinyl]methyl]-3-thiophenecarboxilate), a novel non-peptide angiotensin II receptor antagonist. This compound potently displaced [3H]angiotensin II from angiotensin AT1 (Ki = 1.4 nM, rat adrenal cortex), but not from angiotensin AT2 (Ki > 1 ωM, bovine cerebellar cortex) receptors and did not show affinity for other receptor systems (Ki > 10 ωM). In saturation studies, LR-B/081 both increased KD and decreased Bmax values in a dose-dependent fashion. The rate of dissociation of [3H]angiotenin II from angiotensin AT1 receptors was not affected by the presence of 1 ωM LR-B/081 and the association rate of [3H]angiotensin II was not decreased by the presence of 1 or 30 nM LR-B/081, indicating that the Bmax reduction was not due to an allosteric interaction or to a delay in reaching the steady-state conditions. These data underline the complexity of the antagonistic nature of LR-B/081, presenting features of both competitive and noncompetitive antagonism.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信